Industry
Pharmaceutical & Health Technology
Pharmaceutical, medical-device and health-technology companies seeking market access and evidence of value.
Context
The challenge
Africa's health markets offer real opportunity, but payers, providers and regulation vary widely between countries. Products succeed when they meet a real need and come with credible evidence of value for those who pay.
OGHC supports market access with payer-landscape analysis, health technology assessment and economic evaluation, budget impact models and market intelligence.
Challenges
Issues we help address
- Understanding fragmented payer and provider markets
- Evidence of value for purchasers and insurers
- Health technology assessment requirements
- Pricing and reimbursement strategy
Relevant services
How OGHC helps
- Health Economics and FinancingCosting, affordability analysis, resource allocation, health financing and policy advisory.
- Research and PublicationsMarket research, policy briefs, white papers, reports and health intelligence.
- Health Insurance AdvisoryProduct design, claims, cost containment and provider networks — independent advice for insurers, TPAs and employers.
- Healthcare Policy DevelopmentPolicy research, regulatory analysis, health systems strengthening and strategic health planning.
Working in pharmaceutical & health technology?
Let's discuss the challenges you face and where independent advice can help.